We analyzed morbidity, mortality, and inpatient data from 2021 to 2023, obtained from the Center for Health Development in Mongolia.Background: This study analyzes morbidity, mortality, and inpatient data from Mongolian Traditional Medicine Departments (MTMDs) for the years 2021-2023, focusing on patients diagnosed with arterial hypertension (ICD-10 I10) and rheumatoid arthritis (ICD-10 M05), corresponding to traditional diagnoses of "wind and blood ascending disorder" and "rheumatic diseases," respectively.Methods: Data were collected from the Center for Health Development Mongolia, encompassing 1,398 cases of "wind and blood ascending disorder" and 175 cases of "rheumatic diseases." Variables analyzed included patient demographics, hospitalization duration, and disease status.Results:1. From 2021 to 2023, cases decreased annually (823 in 2021, 404 in 2022, and 171 in 2023). Ulaanbaatar and Zavkhan had the highest prevalence rates (1.5%), while Orkhon had the lowest (0.1%). Admissions peaked in winter and decreased in spring, with significant monthly variations (p<0.05). Most patients (73.2%) were treated in private hospitals, with a mean hospital stay of 7.07±1.73 days. Cases varied across the years (95 in 2021, 34 in 2022, and 46 in 2023). Ulaanbaatar accounted for the majority of hospitalizations (82.1% in 2021, 64.7% in 2022, 30.4% in 2023). Mean hospital stay was 7.3±1.29 days, with significant regional differences (p<0.05).Conclusions:The incidence of "wind and blood ascending disorder" has declined, while admissions to MTMDs have increased. "Rheumatic diseases" showed a variable pattern, with significant regional and temporal differences in hospitalization rates and durations. Further research is needed to understand the underlying causes of these trends and optimize treatment protocols.